Literature DB >> 20510218

Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic Rats.

Jian-Jun Wen1, Shivali Gupta, Zhangjun Guan, Monisha Dhiman, David Condon, Charles Lui, Nisha Jain Garg.   

Abstract

OBJECTIVES: The purpose of this study was to determine the pathological importance of oxidative stress-induced injurious processes in chagasic heart dysfunction.
BACKGROUND: Trypanosoma cruzi-induced inflammatory pathology and a feedback cycle of mitochondrial dysfunction and oxidative stress may contribute to Chagas disease.
METHODS: Sprague-Dawley rats were infected with T. cruzi and treated with phenyl-alpha-tert-butylnitrone (PBN), an antioxidant, and/or benzonidazole (BZ), an antiparasitic agent. We monitored myocardial parasite burden, oxidative adducts, mitochondrial complex activities, respiration, and adenosine triphosphate synthesis rates, and inflammatory and cardiac remodeling responses during disease development. The cardiac hemodynamics was determined for all rats.
RESULTS: Benzonidazole (not PBN) decreased the parasite persistence and immune adverse events (proinflammatory cytokine expression, beta-nicotinamide adenine dinucleotide phosphate oxidase and myeloperoxidase activities, and inflammatory infiltrate) in chronically infected hearts. PBN +/- BZ (not BZ alone) decreased the mitochondrial reactive oxygen species level, oxidative adducts (malonyldialdehyde, 4-hydroxynonenal, carbonyls), hypertrophic gene expression (atrial natriuretic peptide, B-type natriuretic peptide, alpha-skeletal actin), and collagen deposition and preserved the respiratory chain efficiency and energy status in chronically infected hearts. Subsequently, LV dysfunction was prevented in PBN +/- BZ-treated chagasic rats.
CONCLUSIONS: BZ treatment after the acute stage decreased the parasite persistence and inflammatory pathology. Yet, oxidative adducts, mitochondrial dysfunction, and remodeling responses persisted and contributed to declining cardiac function in chagasic rats. Combination treatment (PBN + BZ) was beneficial in arresting the T. cruzi-induced inflammatory and oxidative pathology and chronic heart failure in chagasic rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20510218      PMCID: PMC2887697          DOI: 10.1016/j.jacc.2010.02.030

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

1.  Prevalence of circulating Trypanosoma cruzi detected by polymerase chain reaction in patients with Chagas' cardiomyopathy.

Authors:  O A Salomone; D Juri; M O Omelianiuk; A Sembaj; A M Aguerri; C Carriazo; J M Barral; R Madoery
Journal:  Am J Cardiol       Date:  2000-05-15       Impact factor: 2.778

2.  Oxidative stress in chronic cardiopathy associated with Chagas disease.

Authors:  Tiago Bittencourt de Oliveira; Roberto Coury Pedrosa; Danilo Wilhelm Filho
Journal:  Int J Cardiol       Date:  2006-07-20       Impact factor: 4.164

3.  Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery.

Authors:  D A Leiby; F J Rentas; K E Nelson; V A Stambolis; P M Ness; C Parnis; H A McAllister; D H Yawn; R J Stumpf; L V Kirchhoff
Journal:  Circulation       Date:  2000-12-12       Impact factor: 29.690

Review 4.  Pathogenesis of chronic Chagas heart disease.

Authors:  Jose Antonio Marin-Neto; Edécio Cunha-Neto; Benedito C Maciel; Marcus V Simões
Journal:  Circulation       Date:  2007-03-06       Impact factor: 29.690

5.  Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient.

Authors:  E Jardim; O M Takayanagui
Journal:  J Trop Med Hyg       Date:  1994-12

6.  Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.

Authors:  Ivo Santana Caldas; André Talvani; Sérgio Caldas; Cláudia Martins Carneiro; Marta de Lana; Paulo Marcos da Matta Guedes; Maria Terezinha Bahia
Journal:  Parasitol Res       Date:  2008-05-04       Impact factor: 2.289

7.  Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice.

Authors:  Jian-Jun Wen; Monisha Dhiman; Elbert B Whorton; Nisha Jain Garg
Journal:  Microbes Infect       Date:  2008-07-16       Impact factor: 2.700

8.  Molecular characterization of cytosolic and mitochondrial tryparedoxin peroxidase in Trypanosoma cruzi populations susceptible and resistant to benznidazole.

Authors:  Fernanda B Nogueira; Jerônimo C Ruiz; Carlos Robello; Alvaro J Romanha; Silvane M F Murta
Journal:  Parasitol Res       Date:  2008-11-19       Impact factor: 2.289

9.  Mitochondrial generation of reactive oxygen species is enhanced at the Q(o) site of the complex III in the myocardium of Trypanosoma cruzi-infected mice: beneficial effects of an antioxidant.

Authors:  Jian-Jun Wen; Nisha Jain Garg
Journal:  J Bioenerg Biomembr       Date:  2008-11-14       Impact factor: 2.945

Review 10.  Role of peroxynitrite in the redox regulation of cell signal transduction pathways.

Authors:  Lucas Liaudet; Giuseppe Vassalli; Pal Pacher
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  42 in total

Review 1.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

2.  NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease.

Authors:  Monisha Dhiman; Nisha Jain Garg
Journal:  J Pathol       Date:  2011-09-26       Impact factor: 7.996

Review 3.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

Review 4.  Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment.

Authors:  Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Anthony Howell; Richard G Pestell; Herbert B Tanowitz; Federica Sotgia; Michael P Lisanti
Journal:  Int J Biochem Cell Biol       Date:  2011-02-15       Impact factor: 5.085

5.  Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells.

Authors:  Ubaldo E Martinez-Outschoorn; Richard G Pestell; Anthony Howell; Mark L Tykocinski; Fnu Nagajyothi; Fabiana S Machado; Herbert B Tanowitz; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

6.  Inhibition of NFE2L2-Antioxidant Response Element Pathway by Mitochondrial Reactive Oxygen Species Contributes to Development of Cardiomyopathy and Left Ventricular Dysfunction in Chagas Disease.

Authors:  Jake Jianjun Wen; Craig Porter; Nisha Jain Garg
Journal:  Antioxid Redox Signal       Date:  2017-07-13       Impact factor: 8.401

7.  A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection.

Authors:  Ana Fernández-Villegas; Elena Pérez-Antón; Inmaculada Gómez; Adriana Egui; M Carmen Thomas; Bartolomé Carrilero; Ángel Del Pozo; Maialen Ceballos; Eduardo Andrés-León; Miguel Ángel López-Ruz; Eusebio Gainza; Enrique Oquiñena; Manuel Segovia; Manuel Carlos López
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 8.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

Review 9.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Authors:  Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg
Journal:  Semin Immunopathol       Date:  2012-10-18       Impact factor: 9.623

10.  Serum-mediated activation of macrophages reflects TcVac2 vaccine efficacy against Chagas disease.

Authors:  Shivali Gupta; Trevor S Silva; Jessica E Osizugbo; Laura Tucker; Heidi M Spratt; Nisha J Garg
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.